Cargando…
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a singl...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583874/ https://www.ncbi.nlm.nih.gov/pubmed/34769059 http://dx.doi.org/10.3390/ijms222111630 |
_version_ | 1784597309041934336 |
---|---|
author | Schmitz, Werner Ries, Elena Koderer, Corinna Völter, Maximilian Friedrich Wünsch, Anna Chiara El-Mesery, Mohamed Frackmann, Kyra Kübler, Alexander Christian Linz, Christian Seher, Axel |
author_facet | Schmitz, Werner Ries, Elena Koderer, Corinna Völter, Maximilian Friedrich Wünsch, Anna Chiara El-Mesery, Mohamed Frackmann, Kyra Kübler, Alexander Christian Linz, Christian Seher, Axel |
author_sort | Schmitz, Werner |
collection | PubMed |
description | Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level. |
format | Online Article Text |
id | pubmed-8583874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85838742021-11-12 Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy Schmitz, Werner Ries, Elena Koderer, Corinna Völter, Maximilian Friedrich Wünsch, Anna Chiara El-Mesery, Mohamed Frackmann, Kyra Kübler, Alexander Christian Linz, Christian Seher, Axel Int J Mol Sci Article Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level. MDPI 2021-10-27 /pmc/articles/PMC8583874/ /pubmed/34769059 http://dx.doi.org/10.3390/ijms222111630 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schmitz, Werner Ries, Elena Koderer, Corinna Völter, Maximilian Friedrich Wünsch, Anna Chiara El-Mesery, Mohamed Frackmann, Kyra Kübler, Alexander Christian Linz, Christian Seher, Axel Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title | Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_full | Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_fullStr | Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_full_unstemmed | Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_short | Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_sort | cysteine restriction in murine l929 fibroblasts as an alternative strategy to methionine restriction in cancer therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583874/ https://www.ncbi.nlm.nih.gov/pubmed/34769059 http://dx.doi.org/10.3390/ijms222111630 |
work_keys_str_mv | AT schmitzwerner cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT rieselena cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT koderercorinna cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT voltermaximilianfriedrich cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT wunschannachiara cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT elmeserymohamed cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT frackmannkyra cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT kubleralexanderchristian cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT linzchristian cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT seheraxel cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy |